Ondansetron Pharmathen

Ondansetron, the active ingredient in Ondansetron Pharmathen, is a 5-HT3 receptor antagonist presented as a tablet for oral use. It helps prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients. GNH USA supplies Ondansetron Pharmathen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Pharmathen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron Pharmathen is used to manage nausea and vomiting by targeting the serotonergic pathway involved in emesis.

- Chemotherapy‑induced nausea and vomiting: Reduces the frequency and severity of acute and delayed episodes. - Radiation‑induced nausea and vomiting: Helps control nausea during and after radiotherapy. - Post‑operative nausea and vomiting: Decreases the incidence of nausea and vomiting after surgical procedures. - Pregnancy‑related nausea (off‑label): May be considered when other treatments are ineffective, under physician ​ -